Delivery Order SPE2DB20D1004-SPE2DB22FE8S8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyndamax 61 mg capsules. The $12,345.35 firm fixed-price contract has a period of performance through February 2, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,960.30 delivery order contract is for the medical product Vyndamax 61 mg Capsule UD 30s. The contract has a firm fixed price pricing type and a completion date of June 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,960.30 fixed-price contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, with a period of performance through November 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
- This is a $12,960.30 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, by the Defense Logistics Agency (DLA) for the supply of the drug VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp is the Corporate Office Division of the parent company Cencora, Inc., which does business as Amerisourcebergen. This delivery order is part of a larger Indefinite...
- The U.S. Department of Defense, Medical Supply Chain awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The contract, valued at $49,381.36, is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical in the amount of $12,345.34. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, with a completion date of February 23, 2024. The contract is a firm fixed price arrangement and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Vyndamax 61 mg capsules. The firm-fixed-price, $13,408.24 delivery order contract has an ultimate completion date of March 17, 2025. The award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,846.97 firm fixed-price delivery order is for the supply of Vyndamax 61 mg capsules, with a period of performance through July 30, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,408.24 firm fixed-price contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $12,345.34 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VYNDAMAX 61 MG CAPSULE UD 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FE8S8Delivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyndamax 61 mg capsules. The $12,345.35 delivery order was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has a completion date of December 7, 2021. The contract is a firm-fixed price delivery order, with no set-aside requirements indicated. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 11/15/21 |